Corneal Disorder - Keratoconus Treatment (Corneal Collagen Crosslinking with Riboflavin)

Corneal Collagen Crosslinking with Riboflavin (CXL) is a developing keratoconus treatment.  CXL works by increasing collagen crosslinks which are the natural “anchors” within the cornea. These anchors are responsible for preventing the cornea from bulging out and becoming steep and irregular.

During the corneal crosslinking treatment, riboflavin drops saturate the cornea, which is then activated by ultraviolet light. This process is to increase the amount of collagen cross-linking in the cornea and strengthen the cornea.